Linked Life Data

21336111

Source:http://linkedlifedata.com/resource/pubmed/id/21336111

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2011-5-25
pubmed:abstractText
To compare survival after exchange transfusion followed by hemorrhage using: 1) the vasoactive, oxygen-carrying, bovine hemoglobin-based blood substitute Oxyglobin (Biopure, 12.9 g hemoglobin/dL); and 2) the hydroxyethyl starch plasma expander Hextend (high molecular weight and low degree of substitution, 6%).
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1530-0293
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1461-6
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Vasoactive hemoglobin solution improves survival in hemodilution followed by hemorrhagic shock.
pubmed:affiliation
Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural